The #LungAmbition Alliance is growing with 50+ countries implementing plans to deliver our vision. With greater partnership we can better reach patients and achieve even more. Join the LAA and help change what it means to live with #lungcancer. https://t.co/oiZ1eimZ51
We’re excited to launch Guardant Reveal, the first blood-only #liquidbiopsy test for residual disease and recurrence monitoring of early-stage #colorectalcancer patients. #MRD https://t.co/3GsP9X1vgu
We are hiring! Join an incredible group with an incredible mission. As you can see he and we are all in. What are you looking at...tumor response map..reach out and learn more.